Showing results (1-10 of 216) with videos related to
Sort By:
Pageof 22
Life Sciences|February 2, 1987
Phenylethylamine metabolism to tyramine by postmortem human brain preparationsM E Wolf, A D Mosnaim, O H Callaghan, et al.General Pharmacology|January 1, 1989
Hydroxylation of phenylethylamine by rat liver preparations. Inhibition studiesA D Mosnaim, O H Callaghan, M E WolfGeneral Pharmacology|January 1, 1988
Studies of the in vitro human plasma degradation of methionine-enkephalinA D Mosnaim, J Puente, M E Wolf, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|December 23, 1982
Platelet monoamine oxidase activity and plasma levels of non-catecholic phenylethylamines in insulin-dependent diabetic subjectsA D Mosnaim, F Karoum, A Zeller, et al.International Journal of Clinical Pharmacology and Therapeutics|June 1, 1994
Improvement of axial dystonia with the administration of clozapineM E Wolf, A D MosnaimJournal of Clinical Psychopharmacology|August 1, 1988
Administration of butaperazine and plasma methionine-enkephalin levels in schizophrenic and affective disorder patients with tardive dyskinesiaA D Mosnaim, M E WolfGeneral Pharmacology|January 1, 1983
Phenylethylamine in neuropsychiatric disordersM E Wolf, A D MosnaimAmerican Journal of Therapeutics|July 29, 1999
Effects of the administration of amphetamine, either alone or in combination with reserpine or cocaine, on regional brain beta-phenylethylamine and dopamine releaseF Karoum, M E Wolf, A D MosnaimComparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology|January 1, 1983
Studies in the mechanism of phenylethylamine uptake by rabbit erythrocytesM Mason, M E Wolf, A D MosnaimPsychological Medicine|August 1, 1983
Cognitive functions in tardive dyskinesiaM E Wolf, J J Ryan, A D MosnaimPageof 22